42 Biggest Movers From Yesterday

Gainers

• Yield10 Bioscience Inc YTEN shares jumped 183.59 percent to close at $5.53 on Monday after the company reported granting of research license to Monsanto for evaluation of 2 novel yield traits in soybean.
• ARGENX SE/S ADR ARGX shares climbed 78.88 percent to close at $54.47 after the company reported positive topline results from Phase 2 proof-of-concept trial of ARGX-113 in generalized myasthenia gravis.
• Seven Stars Cloud Group Inc SSC shares surged 47.35 percent to close at $3.61 on Monday.
• Riot Blockchain Inc RIOT shares climbed 45.52 percent to close at $23.08 on Monday after gaining 8.63 percent on Friday.
• Marathon Patent Group Inc MARA shares rose 42.86 percent to close at $6.30 on Monday after declining 3.71 percent on Friday.
• Sunesis Pharmaceuticals, Inc. SNSS jumped 38.71 percent to close at $3.44. Wells Fargo upgraded Sunesis Pharmaceuticals from Market Perform to Outperform.
• U.S. Global Investors, Inc. GROW shares jumped 35.02 percent to close at $5.33.
• Net Element Inc NETE shares surged 34.99 percent to close at $5.44 on Monday.
• Arcimoto Inc FUV shares rose 33.83 percent to close at $3.60.
• Famous Dave's of America, Inc. DAVE shares climbed 32.08 percent to close at $7.00.
• Xunlei Ltd XNET shares rose 29.38 percent to close at $15.50 on Monday.
• Blueprint Medicines Corp BPMC gained 22.91 percent to close at $88.32 on Monday after the company announced new data from ongoing Phase 1 clinical trial of Avapritinib.
• Overstock.com Inc OSTK climbed 22.02 percent to close at $55.00 following 13G filing from Morgan Stanley late Friday showing increased stake from 130,000 shares to 2.87 million shares.
• Clearside BioMedical, Inc. CLSD shares jumped 19.69 percent to close at $7.05.
• bluebird bio Inc BLUE shares rose 17.91 percent to close at $201.80 after the company announced updated clinical results from ongoing Phase 1 multicenter study of LentiGlobin gene therapy in severe sickle cell disease at the ASH2017.
• Chicken Soup for The Soul Entrtnmnt Inc CSSE shares rose 17.04 percent to close at $9.48.
• Social Reality Inc SRAX shares jumped 16.96 percent to close at $6.00. Social Reality Inc announced late Friday a litigation settlement with tronc Inc and Tribune Content Agency over an alleged breach of contract and deceptive business practices. Social Reality also filed for 4,746,820 offering from selling shareholders.
• Consol Energy Inc CEIX shares rose 16.28 percent to close at $29.50 on Monday.
• Intersect ENT Inc XENT shares gained 14.51 percent to close at $32.75 as the company reported the FDA approval of SINUVA Sinus Implant as a treatment option for recurrent nasal polyps.
• Shineco Inc TYHT shares gained 12.77 percent to close at $2.9546 after the company disclosed a Share Exchange and Acquisition deal with Western Xinjiang Tiansheng Agricultural Development Co.
• SunPower Corporation SPWR rose 10.67 percent to close at $9.23. Baird upgraded SunPower from Neutral to Outperform.
• CHF Solutions Inc CHFS shares rose 10.59 percent to close at $3.80 on Monday after climbing 11.00 percent on Friday.
• Catalyst Biosciences Inc CBIO rose 10.21 percent to close at $8.31 as the company announced promising interim Phase 1/2 CB 2679D/ISU304 results at the ASH2017.
• Helios and Matheson Analytics Inc HMNY rose 8.05 percent to close at $9.13 following news of a new marketing and performance-based sales deal with a movie distributor.
• Trade Desk Inc TTD gained 6.74 percent to close at $48.30. SunTrust Robinson Humphrey upgraded Trade Desk from Hold to Buy.

Losers

• Spark Therapeutics Inc ONCE shares tumbled 34.97 percent to close at $47.72 on Monday on volatile factor VIII activity data in hemophilia A gene therapy.
• Syros Pharmaceuticals Inc SYRS dipped 31.69 percent to close at $8.45 following presentation at the ASH 2017 on Phase 2 trial of SY-1425 in genomically defined AML and MDS patients.
• Technical Communications Corporation TCCO shares dropped 21.26 percent to close at $5.00 on Monday. Technical Communications reported a Q4 loss of $0.28 per share on revenue of $1.125 million.
• Wins Finance Holdings Inc WINS shares declined 18.66 percent to close at $47.02.
• Verastem Inc VSTM shares fell 16.86 percent to close at $3.60 after the company announced clinical data from the pivotal Phase 3 DUO study.
• Athenex Inc ATNX shares dropped 16.3 percent to close at $13.37. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.
• Long Island Iced Tea Corp LTEA shares fell 15.59 percent to close at $1.70.
• bebe stores, inc. BEBE shares dipped 15.08 percent to close at $4.73. Bebe stores announced intention to voluntarily delist from the NASDAQ and begin trading on OTCQB.
• Juno Therapeutics Inc JUNO declined 14.34 percent to close at $50.24. Juno Therapeutics and Celgene released additional data from the TRANSCEND trial of JCAR017 in patients with relapsed or refractory aggressive B-cell non-hodgkin lymphoma.
• Co-Diagnostics Inc CODX shares fell 13.64 percent to close at $3.80.
• Trillium Therapeutics Inc TRIL shares dropped 13.33 percent to close at $9.75 on Monday.
• Arsanis Inc ASNS shares declined 12.53 percent to close at $12.22 on Monday.
• Novan Inc NOVN shares slipped 11.16 percent to close at $4.30.
• Ovid Therapeutics Inc OVID shares dropped 10.99 percent to close at $10.45.
• Hornbeck Offshore Services, Inc. HOS shares slipped 10.86 percent to close at $2.79.
• Anavex Life Sciences Corp AVXL shares fell 10.57 percent to close at $3.30. Anavex Life Sciences reported FY17 loss of $0.33 per share, versus a year-ago loss of $0.42 per share.
• Seattle Genetics, Inc. SGEN shares declined 6.74 percent to close at $ 55.265. Seattle Genetics highlighted five-year survival results from Phase 1 trial of ADCETRIS in frontline mature T-cell lymphoma at the ASH 2017.